PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-03-03

Date Title Company
03-Mar-2025 Breast Imaging Market Size to Register $6899.62 Million Globally, by 2030, at 7.40% CAGR Growth Asia Times Korea
03-Mar-2025 Coulter Partners places seasoned medical device R&D leader at Sensome Coulter Partners
03-Mar-2025 Pharmaceutical Water Market Share Rising at 8.3% CAGR to Hit USD 89.9 Billion by 2034 Transparency Market Research
03-Mar-2025 Immunic to Participate in Scientific and Investor Conferences in March Immunic AG
03-Mar-2025 Prescription Drugs Market Size by Application, By Type, By Geographic Scope and Forecast 2025-2035 Asia Times Korea
03-Mar-2025 Global Canine Atopic Dermatitis Market Poised to Reach US$ 431.0 Mn by 2035 Amidst Innovative Treatment Advances | TMR Analysis Transparency Market Research
03-Mar-2025 AI In Oncology For Analytical Solutions Market Size | USD 4852.6 Mn & 36.5% Growth by 2030 Asia Times Korea
03-Mar-2025 Custom Antibody Market Size | USD 1.2 Bn & 9.75% Growth by 2030 Asia Times Korea
03-Mar-2025 Bioadhesives Market Size | USD 12.6 Bn & 10.50% Growth by 2030 Asia Times Korea
03-Mar-2025 Biopreservation Market Size | USD 23.3 Bn & 29.1% Growth by 2030 Asia Times Korea
03-Mar-2025 Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth Novo Holdings
03-Mar-2025 Kelso Pharma’s European growth story continues with appointment of new General Manager in Italy Kelso Pharma
03-Mar-2025 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Genmab
03-Mar-2025 Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab Genmab
03-Mar-2025 AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity AbbVie
03-Mar-2025 Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies Roche
03-Mar-2025 Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP) GSK
03-Mar-2025 Depemokimab delivers clinically meaningful and statistically significant improvements for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) GSK
03-Mar-2025 Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer AstraZeneca
03-Mar-2025 New Bonus Modules for the Certificate GMP Training Pharma Lessons